Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs (Q84540286)
Jump to navigation
Jump to search
scientific article published on 11 July 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs |
scientific article published on 11 July 2011 |
Statements
Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs (English)
Paresh Thakker
Suzana Marusic
Nancy L Stedman
Katherine L Lee
John C McKew
Andrew Wood
Samuel J Goldman
Michael W Leach
Vijay K Kuchroo
Stanley F Wolf
James D Clark
Mina Hassan-Zahraee